Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in children



Document title: Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in children
Journal: Annals of hepatology
Database: PERIÓDICA
System number: 000415058
ISSN: 1665-2681
Authors: 1
1
2
3
4
1
1
5
6
7
8
8
1
9
Institutions: 1Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, México, Distrito Federal. México
2Centro Nacional para la Salud de la Infancia y la Adolescencia, México, Distrito Federal. México
3Instituto Mexicano del Seguro Social, Hospital de Especialidades 71, Torreón, Coahuila. México
4Instituto Nacional de Pediatría, Departamento de Gastroenterología, México, Distrito Federal. México
5Hospital Infantil de México "Federico Gómez", Departamento de Gastroenterología, México, Distrito Federal. México
6Hospital Infantil de México "Federico Gómez", Departamento de Endoscopia, México, Distrito Federal. México
7Hospital para el Niño Poblano, Puebla. México
8Instituto Mexicano del Seguro Social, Centro Médico de Occidente, Guadalajara, Jalisco. México
9Hospital Infantil de México "Federico Gómez", Departamento de Cirugía de Trasplantes, México, Distrito Federal. México
Year:
Volumen: 12
Pages: 3-3s24
Country: México
Language: Inglés
Document type: Artículo
Approach: Analítico, descriptivo
English abstract Extrahepatic portal vein obstruction is an important cause of portal hypertension among children. The etiology is heterogeneous and there are few evidences related to the optimal treatment. Aim and methods. To establish guidelines for the diagnosis and treatment of EHPVO in children, a group of gastroenterologists and pediatric surgery experts reviewed and analyzed data reported in the literature and issued evidence-based recommendations. Results. Pediatric EHPVO is idiopathic in most of the cases. Digestive hemorrhage and/or hypersplenism are the main symptoms. Doppler ultrasound is a non-invasive technique with a high degree of accuracy for the diagnosis. Morbidity is related to variceal bleeding, recurrent thrombosis, portal biliopathy and hypersplenism. Endoscopic therapy is effective in controlling acute variceal hemorrhage and it seems that vasoactive drug therapy can be helpful. For primary prophylaxis of variceal bleeding, there are insufficient data for the use of beta blockers or endoscopic therapy. For secondary prophylaxis, sclerotherapy or variceal band ligation is effective; there is scare evidence to recommend beta-blockers. Surgery shunt is indicated in children with variceal bleeding who fail endoscopic therapy and for symptomatic hypersplenism; spleno-renal or meso-ilio-cava shunting is the alternative when Mesorex bypass is not feasible due to anatomic problems or in centers with no experience. Conclusions. Prospective control studies are required for a better knowledge of the natural history of EHPVO, etiology identification including prothrombotic states, efficacy of beta-blockers and comparison with endoscopic therapy on primary and secondary prophylaxis
Disciplines: Medicina
Keyword: Gastroenterología,
Pediatría,
Sistema cardiovascular,
Terapéutica y rehabilitación,
Guías diagnósticas,
Guías terapéuticas,
Hipertensión portal,
Oclusion vascular,
Vena portal,
Profilaxis
Keyword: Medicine,
Cardiovascular system,
Gastroenterology,
Pediatrics,
Therapeutics and rehabilitation,
Diagnostic guidelines,
Therapeutic guides,
Portal hypertension,
Vascular occlusion,
Portal vein,
Prophylaxis
Full text: Texto completo (Ver PDF)